Insider Trading Activity - Schwab Andrew J.

Real time insider trading transaction history:

Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
Shares are not adjusted for stock split.

"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>

Insider Trading Transactions for Schwab Andrew J.

Goto 0, 1, Next

Common stock purchase or sale:

Transaction Date	Reported DateTime	Company	Symbol	Insider Relationship	Shares Traded	Average Price	Total Amount	Shares Owned	Filing
2024-10-15 Purchase	2024-10-15 5:48 pm	Camp4 Therapeutics Corp	CAMP	Schwab Andrew J. Director 10% Owner	909,090	$11	$9,999,990	2,625,145 (Indirect)	View
2024-09-11 Sale	2024-09-13 6:56 pm	Skye Bioscience Inc.	SKYE	Schwab Andrew J. Director 10% Owner	266,337	$6.5719	$1,750,352	66,277 (Indirect)	View
2024-07-22 Purchase	2024-07-24 4:15 pm	Artiva Biotherapeutics Inc.	ARTV	5AM Partners VI LLC 5AM Ventures VI L.P. 5AM Opportunities II (GP) LLC 5AM Opportunities II L.P. PARMAR KUSH Schwab Andrew J. 10% Owner	833,333	$12	$9,999,996	1,643,741 (Indirect)	View
2024-02-14 Sale	2024-02-16 4:15 pm	Enliven Therapeutics Inc.	ELVN	5AM Partners VI LLC 5AM Ventures VI L.P. 5AM Opportunities I (GP) LLC 5AM Opportunities I L.P. PARMAR KUSH Schwab Andrew J. 10% Owner	825,000	$14.9	$12,292,500	635,341 (Indirect)	View
2024-01-31 Sale	2024-02-02 4:29 pm	Enliven Therapeutics Inc.	ELVN	5AM Partners VI LLC 5AM Ventures VI L.P. 5AM Opportunities I (GP) LLC 5AM Opportunities I L.P. PARMAR KUSH Schwab Andrew J. 10% Owner	500,000	$15	$7,500,000	771,983 (Indirect)	View
2023-09-26 Sale	2023-09-28 4:27 pm	Enliven Therapeutics Inc.	ELVN	5AM Partners VI LLC 5AM Ventures VI L.P. 5AM Opportunities I (GP) LLC 5AM Opportunities I L.P. PARMAR KUSH Schwab Andrew J. 10% Owner	197,500	$15	$2,962,500	854,796 (Indirect)	View
2023-08-24 Sale	2023-08-28 4:20 pm	Enliven Therapeutics Inc.	ELVN	5AM Partners VI LLC 5AM Ventures VI L.P. 5AM Opportunities I (GP) LLC 5AM Opportunities I L.P. PARMAR KUSH Schwab Andrew J. 10% Owner	440,000	$16	$7,040,000	887,507 (Indirect)	View
2023-04-10 Sale	2023-04-12 4:51 pm	Pear Therapeutics Inc.	PEAR	5AM Partners IV LLC 5AM Ventures IV L.P. 5AM Co-Investors IV L.P. 5AM Opportunities I (GP) LLC 5AM Opportunities I L.P. DIEKMAN JOHN D ROCKLAGE SCOTT M Schwab Andrew J. 10% Owner	16,544,113	$0.12	$1,985,294	200,000 (Indirect)	View
2023-03-07 Sale	2023-03-09 4:35 pm	Rallybio Corp	RLYB	5AM Partners V LLC Schwab Andrew J. 5AM Ventures V L.P. ROCKLAGE SCOTT M 10% Owner	100,000	$8.2	$820,000	3,630,724 (Indirect)	View
2022-11-11 Sale	2022-11-15 8:32 pm	Pear Therapeutics Inc.	PEAR	5AM Partners IV LLC 5AM Ventures IV L.P. 5AM Co-Investors IV L.P. 5AM Opportunities I (GP) LLC 5AM Opportunities I L.P. DIEKMAN JOHN D ROCKLAGE SCOTT M Schwab Andrew J. 10% Owner	105,281	$2.7381	$288,267	3,907,624 (Indirect)	View
2022-10-31 Sale	2022-11-02 7:49 pm	Pear Therapeutics Inc.	PEAR	5AM Partners IV LLC 5AM Ventures IV L.P. 5AM Co-Investors IV L.P. 5AM Opportunities I (GP) LLC 5AM Opportunities I L.P. DIEKMAN JOHN D ROCKLAGE SCOTT M Schwab Andrew J. 10% Owner	54,209	$2.7688	$150,096	3,911,835 (Indirect)	View
2022-10-06 Sale	2022-10-11 7:10 pm	scPharmaceuticals Inc.	SCPH	5AM Partners IV LLC 5AM Co-Investors IV L.P. 5AM Opportunities I (GP) LLC 5AM Opportunities I L.P. 5AM Ventures IV L.P. DIEKMAN JOHN D ROCKLAGE SCOTT M Schwab Andrew J. 10% Owner	600,000	$4.1482	$2,488,907	410,268 (Indirect)	View
2022-09-14 Sale	2022-09-16 6:03 pm	Pear Therapeutics Inc.	PEAR	5AM Partners IV LLC 5AM Ventures IV L.P. 5AM Co-Investors IV L.P. 5AM Opportunities I (GP) LLC 5AM Opportunities I L.P. DIEKMAN JOHN D ROCKLAGE SCOTT M Schwab Andrew J. 10% Owner	558,168	$1.8764	$1,047,322	3,914,004 (Indirect)	View
2022-09-06 Sale	2022-09-08 8:01 pm	Pear Therapeutics Inc.	PEAR	5AM Partners IV LLC 5AM Ventures IV L.P. 5AM Co-Investors IV L.P. 5AM Opportunities I (GP) LLC 5AM Opportunities I L.P. DIEKMAN JOHN D ROCKLAGE SCOTT M Schwab Andrew J. 10% Owner	770,000	$2.0543	$1,581,835	3,936,331 (Indirect)	View
2022-09-06 Sale	2022-09-08 7:58 pm	scPharmaceuticals Inc.	SCPH	5AM Partners IV LLC 5AM Co-Investors IV L.P. 5AM Opportunities I (GP) LLC 5AM Opportunities I L.P. 5AM Ventures IV L.P. DIEKMAN JOHN D ROCKLAGE SCOTT M Schwab Andrew J. 10% Owner	226,622	$4.8405	$1,096,953	503,112 (Indirect)	View
2022-08-16 Sale	2022-08-18 8:05 pm	Pear Therapeutics Inc.	PEAR	5AM Partners IV LLC 5AM Ventures IV L.P. 5AM Co-Investors IV L.P. 5AM Opportunities I (GP) LLC 5AM Opportunities I L.P. DIEKMAN JOHN D ROCKLAGE SCOTT M Schwab Andrew J. 10% Owner	400,000	$1.6501	$660,060	3,967,131 (Indirect)	View
2022-08-15 Purchase	2022-08-17 8:01 pm	CinCor Pharma Inc.	CINC	5AM Partners VI LLC 5AM Ventures VI L.P. 5AM Opportunities I (GP) LLC 5AM Opportunities I L.P. Schwab Andrew J. PARMAR KUSH 5AM Opportunities II (GP) LLC 5AM Opportunities II L.P. 10% Owner	600,000	$30	$18,000,000	983,656 (Indirect)	View
2022-06-03 Sale	2022-06-07 5:02 pm	Rallybio Corp	RLYB	5AM Opportunities I L.P. Schwab Andrew J. 5AM Opportunities I (GP) LLC 5AM Partners V LLC 5AM Ventures V L.P. ROCKLAGE SCOTT M 10% Owner	150,000	$12.5	$1,875,000	2,478,969 (Indirect)	View
2022-05-23 Sale	2022-05-25 6:31 pm	Rallybio Corp	RLYB	5AM Opportunities I L.P. Schwab Andrew J. 5AM Opportunities I (GP) LLC 5AM Partners V LLC 5AM Ventures V L.P. ROCKLAGE SCOTT M 10% Owner	100,000	$13	$1,300,000	2,578,640 (Indirect)	View
2022-04-11 Sale	2022-04-13 4:51 pm	scPharmaceuticals Inc.	SCPH	5AM Partners IV LLC 5AM Co-Investors IV L.P. 5AM Opportunities I (GP) LLC 5AM Opportunities I L.P. 5AM Ventures IV L.P. DIEKMAN JOHN D ROCKLAGE SCOTT M Schwab Andrew J. 10% Owner	270,000	$5	$1,350,000	537,301 (Indirect)	View
2022-02-08 Sale	2022-02-10 6:24 pm	Rallybio Corp	RLYB	5AM Opportunities I L.P. Schwab Andrew J. 5AM Opportunities I (GP) LLC 5AM Partners V LLC 5AM Ventures V L.P. ROCKLAGE SCOTT M 10% Owner	210,000	$13.05	$2,740,500	2,645,087 (Indirect)	View
2022-01-11 Purchase	2022-01-13 4:45 pm	CinCor Pharma Inc.	CINC	5AM Partners VI LLC 5AM Ventures VI L.P. 5AM Opportunities I (GP) LLC 5AM Opportunities I L.P. Schwab Andrew J. PARMAR KUSH 10% Owner	470,000	$16	$7,520,000	496,323 (Indirect)	View

Stock options: Exercise, Award, Grant, Conversion

Transaction Date	Reported DateTime	Exercisable Expiration	Company	Symnbol	Insider Relationship	Shares Traded	Conversion Price	Shares Owned	Filing
2025-02-24 Option Award	2025-02-26 7:45 pm	N/A 2035-02-25	Skye Bioscience Inc.	SKYE	Schwab Andrew J. Director	35,000	$0	35,000 (Direct)	View
2024-10-28 Option Award	2024-10-30 8:30 pm	N/A 2034-10-27	Skye Bioscience Inc.	SKYE	Schwab Andrew J. Director	70,000	$0	70,000 (Direct)	View
2024-10-15 Conversion	2024-10-15 5:48 pm	N/A N/A	Camp4 Therapeutics Corp	CAMP	Schwab Andrew J. Director 10% Owner	24,661,577	$0	2,625,145 (Indirect)	View
Ownership	2024-10-10 9:05 pm	N/A N/A	Camp4 Therapeutics Corp	CAMP	Schwab Andrew J. Director 10% Owner	0	$0	2,018,825 (Indirect)	View
2024-07-22 Other	2024-07-24 4:15 pm	N/A N/A	Artiva Biotherapeutics Inc.	ARTV	5AM Partners VI LLC 5AM Ventures VI L.P. 5AM Opportunities II (GP) LLC 5AM Opportunities II L.P. PARMAR KUSH Schwab Andrew J. 10% Owner	461,687	$10.2	1,643,741 (Indirect)	View
2024-07-22 Conversion	2024-07-24 4:15 pm	N/A N/A	Artiva Biotherapeutics Inc.	ARTV	5AM Partners VI LLC 5AM Ventures VI L.P. 5AM Opportunities II (GP) LLC 5AM Opportunities II L.P. PARMAR KUSH Schwab Andrew J. 10% Owner	2,116,568	$0	1,643,741 (Indirect)	View
Ownership	2024-07-18 8:06 pm	N/A N/A	Artiva Biotherapeutics Inc.	ARTV	5AM Partners VI LLC 5AM Ventures VI L.P. PARMAR KUSH Schwab Andrew J. 10% Owner	0	$0	1,058,284 (Indirect)	View
2024-03-13 Option Award	2024-03-15 4:15 pm	N/A N/A	Skye Bioscience Inc.	SKYE	Schwab Andrew J. Director 10% Owner	450,000	$10	10,179,505 (Indirect)	View
2024-02-29 Option Award	2024-03-04 4:04 pm	N/A 2034-03-01	Skye Bioscience Inc.	SKYE	Schwab Andrew J. Director	35,000	$0	35,000 (Direct)	View
2024-01-31 Option Award	2024-02-02 4:35 pm	N/A N/A	Skye Bioscience Inc.	SKYE	Schwab Andrew J. Director 10% Owner	5,206,074	$2.31	9,729,505 (Indirect)	View
2023-11-06 Option Award	2023-11-06 8:29 pm	N/A 2033-08-25	Skye Bioscience Inc.	SKYE	Schwab Andrew J. Director	14,110	$0	20,001 (Direct)	View
2023-08-25 Option Award	2023-08-29 9:36 pm	N/A 2033-08-25	Skye Bioscience Inc.	SKYE	Schwab Andrew J. Director	1,472,692	$0	1,472,692 (Direct)	View
2023-08-18 Option Award	2023-08-22 5:21 pm	N/A N/A	Skye Bioscience Inc.	SKYE	Schwab Andrew J. Director 10% Owner	852,696,240	$0.0103	443,296,919 (Indirect)	View
2023-08-18 Option Award	2023-08-22 5:21 pm	2023-08-18 2033-08-18	Skye Bioscience Inc.	SKYE	Schwab Andrew J. Director 10% Owner	704,509,037	$0	443,296,919 (Indirect)	View
2023-02-23 Option Award	2023-04-06 8:22 pm	N/A 2033-02-23	Enliven Therapeutics Inc.	ELVN	Schwab Andrew J. Director 10% Owner	27,567	$0	27,567 (Direct)	View
2023-02-24 Equity Swap	2023-02-28 4:29 pm	N/A N/A	CinCor Pharma Inc.	CINC	5AM Partners VI LLC 5AM Ventures VI L.P. 5AM Opportunities I L.P. Schwab Andrew J. PARMAR KUSH 5AM Opportunities II (GP) LLC 5AM Opportunities II L.P. 5AM Opportunities I (GP) LLC 10% Owner	4,937,646	$0	0 (Indirect)	View
2023-02-23 Option Award	2023-02-27 9:55 pm	N/A N/A	Enliven Therapeutics Inc.	ELVN	Schwab Andrew J. Director	5,798,475	$0	960,383 (Indirect)	View
2022-11-30 Equity Swap	2022-12-02 3:38 pm	N/A N/A	Akouos Inc.	AKUS	5AM Ventures V L.P. 5AM Partners V LLC 5AM Opportunities I L.P. 5AM Opportunities I (GP) LLC ROCKLAGE SCOTT M Schwab Andrew J. 10% Owner	4,135,786	$0	0 (Indirect)	View
2022-01-11 Conversion	2022-01-13 4:45 pm	N/A N/A	CinCor Pharma Inc.	CINC	5AM Partners VI LLC 5AM Ventures VI L.P. 5AM Opportunities I (GP) LLC 5AM Opportunities I L.P. Schwab Andrew J. PARMAR KUSH 10% Owner	17,017,645	$0	496,323 (Indirect)	View
Ownership	2022-01-06 9:02 pm	N/A N/A	CinCor Pharma Inc.	CINC	5AM Partners VI LLC 5AM Ventures VI L.P. 5AM Opportunities I (GP) LLC 5AM Opportunities I L.P. Schwab Andrew J. PARMAR KUSH 10% Owner	0	$0	3,867,646 (Indirect)	View
2021-12-03 Option Award	2021-12-07 5:25 pm	N/A N/A	Pear Therapeutics Inc.	PEAR	Schwab Andrew J. Director 10% Owner	200,000	$10	3,372,769 (Indirect)	View
2021-12-03 Option Award	2021-12-07 5:25 pm	N/A N/A	Pear Therapeutics Inc.	PEAR	Schwab Andrew J. Director 10% Owner	18,431,771	$0	3,372,769 (Indirect)	View

Goto 0, 1, Next

Insider Trading & Ownership - Schwab Andrew J.